The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 2/Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Folakunmi on 2024-4-9

Curated date: 2024/03/29

Curator: Scholastica

Revision editor(s): Scholastica

Source: Fig. 3B, Supp. Table S7

Description: Differential abundance between responders and non-responders to Anti–PD-1/PD-L1 immunotherapy in patients with Colorectal Cancer (CRC)

Abundance in Group 1: increased abundance in Responders (colorectal cancer - CRC)

NCBI	Quality Control	Links
Bacteroides
Dialister
Flavonifractor
Lachnoclostridium
Lachnospira
Parabacteroides
Ruminococcaceae bacterium UCG-005
Lachnospiraceae_AC2044_groupLachnospiraceae_AC2044_group
Ruminococcus_2Ruminococcus_2
uncultured Lachnospiraceae bacterium

Revision editor(s): Scholastica